| Literature DB >> 35742280 |
Hyo-Jeong Cha1, Kwi-Baek Kim2, Seung-Yup Baek3.
Abstract
The risk of dementia increases with age. To mitigate this risk, we examined the effect of a square-stepping exercise (SSE) program on fall-related fitness and brain-derived neurotrophic factor (BDNF) levels. Twenty older adults in Korea were randomly assigned to either the experimental or control group (each group n = 10). Participants performed SSE for 70 min per session, twice a week, for 12 weeks with a certified instructor. The average age of the participants was 74.80 ± 6.763 years in the exercise group and 72.50 ± 6.519 years in the control group. The experiment group showed significant improvement (p < 0.01) in the lower muscle strength post-intervention. The paired t-test revealed a significant improvement (p < 0.01) in the experimental group and a significant difference in the interaction effect (p < 0.01) in the BDNF levels. There was a significant improvement (p < 0.05) in the BDNF levels in the experimental group and a significant decrease (p < 0.05) in the control group. The SSE program had a positive effect on fall-related fitness and BDNF levels.Entities:
Keywords: balance; cognitive function; leg strength; muscle strength; neurodegenerative disease
Mesh:
Substances:
Year: 2022 PMID: 35742280 PMCID: PMC9222997 DOI: 10.3390/ijerph19127033
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1Examples of square-stepping exercise patterns.
Square-stepping exercise implementation method.
| Section | Contents | Time | |
|---|---|---|---|
| Warm-up | Walking and stretching | 10 min | |
| 1 week | Main exercise | Beginner level 1 | 50 min |
| 2–3 weeks | Beginner level 1 | 25 min | |
| Beginner level 2 | 25 min | ||
| 4–12 weeks | Beginner level 1~2 | 10 min | |
| Review | 10 min | ||
| New pattern (intermediate level) | 30 min | ||
| Cool-down | Stretching | 10 min |
Figure 2Summary of assay protocol. BDNF, brain-derived neurotrophic factor.
Participant characteristics.
| Characteristics | Exercise Group ( | Control Group ( |
|---|---|---|
| Age (years), mean ± SD | 74.80 ± 6.763 | 72.50 ± 6.519 |
| Height (cm) | 158.12 ± 7.724 | 160.39 ± 6.327 |
| Weight (kg) | 58.10 ± 7.214 | 59.80 ± 8.220 |
| Sex (M:F) | 3:7 | 3:7 |
| Fall experience (yes:no) | 2:8 | 5:5 |
| MMSE (range 0–30) | 26.10 ± 2.885 | 26.20 ± 3.327 |
Note: SD, standard deviation; M, male; F, female; MMSE, Mini-Mental State Examination.
Results of two-way ANOVA.
| Item | Source | SS | DF | MS | F-Value |
| |
|---|---|---|---|---|---|---|---|
| Muscle strength of lower extremities | Between | ||||||
| Group (A) | 348.100 | 1 | 348.100 | 3.542 | 0.076 | ||
| Error | 1768.800 | 18 | 98.267 | ||||
| Within | |||||||
| Time (B) | 12.100 | 1 | 12.100 | 2.357 | 0.142 | ||
| A × B | 62.500 | 1 | 62.500 | 12.175 | 0.003 ** | ||
| Error | 92.400 | 18 | 5.133 | ||||
| Balance | Between | ||||||
| Group (A) | 92.598 | 1 | 92.598 | 0.530 | 0.476 | ||
| Error | 3142.287 | 18 | 174.571 | ||||
| Within | |||||||
| Time (B) | 9.428 | 1 | 9.428 | 7.548 | 0.013 * | ||
| A × B | 266.153 | 1 | 266.153 | 7.548 | 0.013 * | ||
| Error | 634.709 | 18 | 35.262 | ||||
| BDNF | Between | ||||||
| Group (A) | 400678.287 | 1 | 400678.287 | 3.142 | 0.093 | ||
| Error | 2295244.645 | 18 | 127513.591 | ||||
| Within | |||||||
| Time (B) | 1333.217 | 1 | 1333.217 | 0.165 | 0.690 | ||
| A × B | 122723.192 | 1 | 122723.192 | 15.148 | 0.001 ** | ||
| Error | 145829.277 | 18 | 8101.627 | ||||
| IGF-1 | Between | ||||||
| Group (A) | 2719.201 | 1 | 2719.201 | 1.000 | 0.331 | ||
| Error | 48952.245 | 18 | 2719.569 | ||||
| Within | |||||||
| Time (B) | 4452.100 | 1 | 4452.100 | 9.989 | 0.005 ** | ||
| A × B | 1879.641 | 1 | 1879.641 | 4.217 | 0.055 | ||
| Error | 8022.629 | 18 | 445.702 |
Note: * p < 0.05; ** p < 0.01; ANOVA, analysis of variance; SS, sum of square; DF, degrees of freedom; MS, mean square; BDNF, brain-derived neurotrophic factor; IGF-1, insulin-like growth factor.
Paired t-test results.
| Item | Group | N | Time of Measurement | DF | t |
| |
|---|---|---|---|---|---|---|---|
| Pre | Post | ||||||
| Muscle strength of lower extremities (repetitions) | Exercise | 10 | 22.20 ± 6.97 | 25.80 ± 9.02 | 9 | −4.070 | 0.003 ** |
| Control | 10 | 18.80 ± 5.20 | 17.40 ± 7.06 | 9 | 1.242 | 0.246 | |
| Balance(s) | Exercise | 10 | 9.00 ± 9.89 | 15.13 ± 9.57 | 9 | −2.034 | 0.072 |
| Control | 10 | 11.12 ± 13.42 | 6.93 ± 7.09 | 9 | 1.868 | 0.095 | |
| BDNF (pg/mL) | Exercise | 10 | 1393.00 ± 208.88 | 1492.23 ± 256.59 | 9 | −2.312 | 0.046 * |
| Control | 10 | 1303.61 ± 289.28 | 1181.28 ± 279.43 | 9 | 3.271 | 0.010 * | |
| IGF-1 (ng/mL) | Exercise | 10 | 147.45 ± 42.87 | 140.06 ± 50.58 | 9 | 0.952 | 0.366 |
| Control | 10 | 144.67 ± 39.87 | 109.86 ± 18.56 | 9 | 3.205 | 0.011 * | |
Note: * p < 0.05; ** p < 0.01; BDNF, brain-derived neurotrophic factor; IGF-1, insulin-like growth factor
Independent t-test results.
| Item | Time of Measurement | Group | t |
| |
|---|---|---|---|---|---|
| Exercise ( | Control ( | ||||
| Muscle strength of lower extremities (repetitions) | Pre | 22.20 ± 6.97 | 18.80 ± 5.20 | 1.236 | 0.232 |
| Post | 25.80 ± 9.02 | 17.40 ± 7.06 | 2.320 | 0.032 * | |
| Balance(s) | Pre | 9.00 ± 9.89 | 11.12 ± 13.42 | −0.401 | 0.693 |
| Post | 15.13 ± 9.57 | 6.93 ± 7.09 | 2.179 | 0.043 * | |
| BDNF (pg/mL) | Pre | 1393.00 ± 208.88 | 1303.61 ± 289.28 | 0.792 | 0.439 |
| Post | 1492.23 ± 256.59 | 1181.28 ± 279.43 | 2.592 | 0.018 * | |
| IGF-1 (ng/mL) | Pre | 147.45 ± 42.87 | 144.67 ± 39.87 | 0.150 | 0.882 |
| Post | 140.06 ± 50.58 | 109.86 ± 18.56 | 1.772 | 0.093 | |
Note: * p < 0.05; BDNF, brain-derived neurotrophic factor; IGF-1, insulin-like growth factor.